Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"

An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus

NCT02771093 ·Status: COMPLETED ·Phase: PHASE4

The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

NCT02582814 ·Status: COMPLETED ·Phase: PHASE3

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

NCT00530309 ·Status: COMPLETED ·Phase: PHASE1

Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes

NCT02220907 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes

NCT03940183 ·Status: COMPLETED ·Phase: PHASE3

Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus

NCT02284269 ·Status: UNKNOWN

A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus

NCT02175784 ·Status: COMPLETED ·Phase: PHASE4

Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

NCT02479399 ·Status: COMPLETED

A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

NCT01023945 ·Status: COMPLETED ·Phase: PHASE1

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

NCT01945216 ·Status: COMPLETED

A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes

NCT03322631 ·Status: COMPLETED ·Phase: PHASE1

Special Survey for Patients With Type 1 or Type 2 Diabetes

NCT01538589 ·Status: COMPLETED

A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years

NCT01681550 ·Status: UNKNOWN ·Phase: NA

Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

NCT00763022 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes

NCT00628212 ·Status: COMPLETED ·Phase: PHASE2

Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

NCT00762190 ·Status: TERMINATED ·Phase: PHASE3

A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients

NCT00336310 ·Status: UNKNOWN ·Phase: PHASE4

Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus

NCT01387737 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

NCT01072331 ·Status: COMPLETED ·Phase: PHASE3

Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

NCT02291874 ·Status: COMPLETED ·Phase: PHASE4

Dose Response Study in Japanese Patients

NCT00261417 ·Status: TERMINATED ·Phase: PHASE2

Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01294436 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus

NCT02529449 ·Status: COMPLETED ·Phase: PHASE2

Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment

NCT00213109 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

NCT03761797 ·Status: COMPLETED